A combination of three different drugs that block the HER-2 receptor, a critical cellular growth signal for some breast cancers, eradicated aggressive breast tumors in mice and could point the way toward developing better treatments in patients, said researchers from the Breast Center at Baylor College of Medicine in a report that appears today in the Journal of the National Cancer Institute.
Scientists have discovered a way to distinguish pancreatic cancer from non-cancerous tissue, new research shows. The method may also distinguish patients who will survive longer than two years.
Echoing recent FDA warnings, a research group from Northern Ireland cautions against over-aggressive use of a group of drugs called “erythropoiesis-stimulating agents” (ESAs) to treat anemia in some cancer patients, according to a commentary in the April issue of the Oncologist, published by AlphaMed Press.
A new class of compounds developed by two University of Kentucky researchers shows promise as a nontoxic treatment of some cancers previously treated with toxic chemotherapy, the researchers report today.
While new findings from Ohio State University scientists suggest a genetic marker that could help distinguish between chronic pancreatitis and pancreatic cancer and gauge who will do well with cancer treatment, a pharmacologist at the Kimmel Cancer Center at Jefferson in Philadelphia sees the discovery as much more.
Research teams at Yale University and the University of Rhode Island have demonstrated a new way to target and potentially treat tumors using a short piece of protein that acts like a nanosyringe to deliver “tags” or therapy to cells, according to a report in the Proceedings of the National Academy of Sciences.
The unique application of operations research to the treatment of prostate cancer allowed Memorial Sloan-Kettering Cancer Center to better Fortune 500 companies last night and win an international competition for best project by an organization.
Deaths from severe heart attacks following admission to hospital have nearly halved in six years as a result of advances in medical treatment. In the largest study of its kind, research led by the University of Edinburgh, analyzed hospital treatment and outcomes for 44,372 patients admitted to 113 hospitals in 14 countries with heart attacks or unstable angina (threatened heart attacks).
A compound derived from green tea greatly diminished the neurotoxicity of proteins secreted by the human immunodeficiency virus, suggesting a new approach to the prevention and treatment of HIV-associated dementia, also known as AIDS dementia complex. The disorder is the most severe form of HIV-related neuropsychiatric impairment.
Variants of two genes involved in the inflammatory system appear to protect patients from suffering a decline in mental function following heart surgery.